221 related articles for article (PubMed ID: 22201755)
41. Amyloid-beta metal interaction and metal chelation.
Cuajungco MP; Frederickson CJ; Bush AI
Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
[TBL] [Abstract][Full Text] [Related]
42. The role of metals in the etiology of Alzheimer's disease.
Shcherbatykh I; Carpenter DO
J Alzheimers Dis; 2007 May; 11(2):191-205. PubMed ID: 17522444
[TBL] [Abstract][Full Text] [Related]
43. Copper and Zinc Dysregulation in Alzheimer's Disease.
Sensi SL; Granzotto A; Siotto M; Squitti R
Trends Pharmacol Sci; 2018 Dec; 39(12):1049-1063. PubMed ID: 30352697
[TBL] [Abstract][Full Text] [Related]
44. Novel drug targets based on metallobiology of Alzheimer's disease.
Bandyopadhyay S; Huang X; Lahiri DK; Rogers JT
Expert Opin Ther Targets; 2010 Nov; 14(11):1177-97. PubMed ID: 20942746
[TBL] [Abstract][Full Text] [Related]
45. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
[TBL] [Abstract][Full Text] [Related]
46. The metal theory of Alzheimer's disease.
Bush AI
J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
[TBL] [Abstract][Full Text] [Related]
47. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
[TBL] [Abstract][Full Text] [Related]
48. Metal chelation as a potential therapy for Alzheimer's disease.
Cuajungco MP; Fagét KY; Huang X; Tanzi RE; Bush AI
Ann N Y Acad Sci; 2000; 920():292-304. PubMed ID: 11193167
[TBL] [Abstract][Full Text] [Related]
49. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.
Schrag M; Crofton A; Zabel M; Jiffry A; Kirsch D; Dickson A; Mao XW; Vinters HV; Domaille DW; Chang CJ; Kirsch W
J Alzheimers Dis; 2011; 24(1):137-49. PubMed ID: 21187585
[TBL] [Abstract][Full Text] [Related]
50. The metallobiology of Alzheimer's disease.
Bush AI
Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772
[TBL] [Abstract][Full Text] [Related]
51. The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.
Greenough MA
J Mol Neurosci; 2016 Nov; 60(3):289-297. PubMed ID: 27558108
[TBL] [Abstract][Full Text] [Related]
52. Iron in Alzheimer's Disease: From Physiology to Disease Disabilities.
Pal A; Cerchiaro G; Rani I; Ventriglia M; Rongioletti M; Longobardi A; Squitti R
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139084
[TBL] [Abstract][Full Text] [Related]
53. Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.
Kabir MT; Uddin MS; Zaman S; Begum Y; Ashraf GM; Bin-Jumah MN; Bungau SG; Mousa SA; Abdel-Daim MM
Mol Neurobiol; 2021 Jan; 58(1):1-20. PubMed ID: 32889653
[TBL] [Abstract][Full Text] [Related]
54. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease.
Cristóvão JS; Santos R; Gomes CM
Oxid Med Cell Longev; 2016; 2016():9812178. PubMed ID: 26881049
[TBL] [Abstract][Full Text] [Related]
55. Metal-associated amyloid-β species in Alzheimer's disease.
Pithadia AS; Lim MH
Curr Opin Chem Biol; 2012 Apr; 16(1-2):67-73. PubMed ID: 22366383
[TBL] [Abstract][Full Text] [Related]
56. The role of metals in modulating metalloprotease activity in the AD brain.
Filiz G; Price KA; Caragounis A; Du T; Crouch PJ; White AR
Eur Biophys J; 2008 Mar; 37(3):315-21. PubMed ID: 18270696
[TBL] [Abstract][Full Text] [Related]
57. Transition metal chelator therapy--a potential treatment for Alzheimer's disease?
Gnjec A; Fonte JA; Atwood C; Martins RN
Front Biosci; 2002 Apr; 7():d1016-23. PubMed ID: 11897554
[TBL] [Abstract][Full Text] [Related]
58. Lipid peroxidation in Alzheimer's disease: emphasis on metal-mediated neurotoxicity.
Obulesu M; Venu R; Somashekhar R
Acta Neurol Scand; 2011 Nov; 124(5):295-301. PubMed ID: 21303349
[TBL] [Abstract][Full Text] [Related]
59. A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease.
Dingwall C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):571-3. PubMed ID: 17511654
[TBL] [Abstract][Full Text] [Related]
60. Metal Binding by GMP-1 and Its Pyrimido [1, 2]benzimidazole Analogs Confirms Protection Against Amyloid-β Associated Neurotoxicity.
Kumar R; Pavlov PF; Winblad B
J Alzheimers Dis; 2020; 73(2):695-705. PubMed ID: 31839606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
